Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Natera Terminates Qiagen Agreement for Developing NGS-Based Genetic Tests

Natera Terminates Qiagen Agreement for Developing NGS-Based Genetic Tests

Mar 12, 2020
|
staff reporter

NEW YORK – Natera said after the close of the market on Thursday that on March 8, it terminated its license, development, and distribution agreement with Qiagen to develop and distribute next-gen sequencing-based genetic tests.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

From the Recovered

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota Cold Case Arrest

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Editing Squid

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

Science Papers Examine Human Fetal Microglia Development, Structure of Adenine Base Editor ABE8e

In Science this week: chromatin accessibility of microglia during fetal development, and more.

What's Popular?

In Business News

  1. Double-Barcoded Single-Cell Library Prep Solves Index-Hopping Issues, Lowers Sequencing Costs

    Premium

  2. Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues

    Premium

  3. People in the News: New Appointments at Talis Biomedical, Veracyte, Aegea Biotechnologies, More

  4. Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease

    Premium

  5. Exact Sciences Q2 Revenues Up 35 Percent, Buoyed by COVID-19 Testing Sales

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.